Wanbury Limited successfully completes ANVISA audit at its Tanuku plant

Wanbury Limited has successfully completed the Brazilian Health Authority (ANVISA) audit at it's Tanuku plant facility, in the month of December 2024 without any observations.

This will enable the Company to maintain and further solidify its position in this important market.

The facility has been upgraded to meet all global regulatory requirements and should meet the highest level of compliance standards.

With the completion of upgradation, the Company has started full-fledged manufacturing operations and the plant will now be running at optimum capacity to meet customer demand.

The Company has a robust order book for the Q4 quarter and should see pick up in sales momentum during the forthcoming quarters.

Shares of Wanbury Limited was last trading in BSE at Rs. 289.90 as compared to the previous close of Rs. 299.65. The total number of shares traded during the day was 27681 in over 230 trades.

The stock hit an intraday high of Rs. 304.10 and intraday low of 284.70. The net turnover during the day was Rs. 8042543.00.

Source : Equity Bulls

Keywords

Wanbury INE107F01022 TanukuPlant ANVISA Audit ZeroObservations